The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

dc.contributor.authorI Sáenz de Tejada
dc.contributor.authorJavier Angulo
dc.contributor.authorPedro Cuevas
dc.contributor.authorAranzazu Fernández-Martínez
dc.contributor.authorIgnacio Moncada
dc.contributor.authorA Allona
dc.contributor.authorEva M Peñas- LLedó
dc.contributor.authorHG Körschen
dc.contributor.authorUlrich Niewöhner
dc.contributor.authorHelmut Haning
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:01:08Z
dc.date.available2026-03-22T14:01:08Z
dc.date.issued2001
dc.descriptionCitaciones: 231
dc.identifier.doi10.1038/sj.ijir.3900726
dc.identifier.urihttps://doi.org/10.1038/sj.ijir.3900726
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44064
dc.language.isoen
dc.publisherSpringer Nature
dc.relation.ispartofInternational Journal of Impotence Research
dc.sourceFundación para el Desarrollo de la Ecología
dc.subjectVardenafil
dc.subjectcGMP-specific phosphodiesterase type 5
dc.subjectSildenafil
dc.subjectIn vivo
dc.subjectSodium nitroprusside
dc.subjectPhosphodiesterase 3
dc.subjectPharmacology
dc.subjectNitric oxide
dc.subjectIC50
dc.subjectPotency
dc.titleThe phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil
dc.typearticle

Files